Medical Devices IRB Determination IRB Member Continuing Education.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Development Cycle of Medical Devices: A Path of Opportunities for Information Professionals Donna Gay Pharma & Health Tech Div, SLA 2007 Spring Meeting.
Investigational Device Exemption (IDE) Overview for IRBs
Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,
Regulatory Pathway for Platform Technologies
Investigational Device Exemptions 21 CFR Part 812
IRB Process & Medical Devices
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Regulation of Medical Devices Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation.
Barbara Gibson, MS, RN, CCRC, CIP, CHRC Regulatory Affairs Officer Vanderbilt Human Research Protection Program.
IRB Review of Device Research and Other Clinical Uses of Devices
Single Use Expanded Access IND/IDE: FDA and IRB Requirements Before and After Use IRB Webinar October 9,2014.
Capturing and Reporting Adverse Events in Clinical Research
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting Special IND/IDE Considerations: Emergency Use of Investigational Product Compassionate Use & Emergency Research July 21,
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
Special Topics in IND Regulation
Medical Devices Approval Process
Educate fund connect support MIAP – Introduction to INDs and IDEs E Mitchell Seymour, PhD RAC Research Faculty Regulatory Project Manager.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
Investigational New Drug Application 21 CFR Part 312 A Review for OCRA US RAC Study Group September 2005 Ginger Clasby, MS Promedica International
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
Weaving regulations into sound value analysis processes Barbara Strain, MA, SM(ASCP) Director Value Management University of Virginia Health System.
Product Definition Chapter 4. What is a Medical Device? FDA: “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent,
Continuing Review VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
1 THE UNIQUE ROLES OF IRB IN MEDICAL DEVICE CLINICALL TRIAL Chiu Lin, Ph.D. CITI, May, 2009 CITI, May, 2009.
Device Research Presented by Marian Serge, R.N.. Goals Identify devices Recognize difference between significant risk (SR) and non- significant risk (NSR)
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
Regulatory Considerations for Investigational Assays: Planning for Success Elizabeth Mansfield, PhD OIVD/FDA “Next-Generation DNA Sequencing as a Tool.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
1 Importation of Medical Devices FDA Chicago District O’Hare Import Resident Post August 26, 2010 Import Entry Review Team Tamara M. Qtami, CSO.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
Institutional Review Board (IRB) Human Subject Dr. John N. Austin, Director and Ms. Renee S. Jones, Associate Director Delaware State University Office.
When do I need an IND ? FDA Guidance for Industry – Investigation New Drug Applications (INDs) - Determining Whether Human Research Studies Can Be Conducted.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
Compliance with FDA Regulations: Collecting, Transmitting and Managing Clinical Information Dan C Pettus Senior Vice President iMetrikus, Inc.
Questions: AAHRPP Evaluation Instrument for Use with Final Revised Accreditation Standards Presented by: C. Karen Jeans, MSN, CCRN, CIP COACH Program Analyst,
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
TUN IRB: The Basics February 26, IRB Function Review human-subject research Ensure the rights & welfare of human subjects are adequately protected.
Investigational Devices and Humanitarian Use Devices June 2007.
Regulatory requirements: children, assent, and consent waivers and waiver of documentation Bob Craig, 2007.
Welcome New IRB Member! This brief presentation covers: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
Protecting Human Subjects in Research A Primer on Understanding the Scope, Purpose, and Process of the Kaplan University IRB Prepared by the Office of.
BIORESEARCH MONITORING & IN VITRO DIAGNOSTIC DEVICES Presented by Jean Toth-Allen, Ph.D. Biophysicist/Consumer Safety Officer Division of Bioresearch Monitoring.
HUD and Emergent Use Walter Kraft. Device Classification Significant risk – Often involve an invasive procedure for implantation or use – Requires IDE.
Human Specimen Repositories Requirements of 21 CFR Parts 50 & 56 PRIM & R May 5, 2004 Sally A. Hojvat, Ph.D. Director of Microbiology Devices Office of.
Drug Development and IND Process GC 690 Walter Kraft, MD.
Michigan Research Ethics Conference M. Ammar Hatahet, MD, MPH, FACP Clinical Professor of Medicine, Michigan State University Chair, Centralized IRB, McLaren.
PD233: Design of Biomedical Devices and Systems (Lecture 2) Dr. Manish Arora CPDM, IISc Course Website:
GCP AND MEDICAL DEVICES
What Are the FDA Requirements for Submitting an IDE?
COCE Institutional Review Board Academic Spotlight
IRB BASICS Ethics and Human Subject Protections Summer 2016
Andrew Farb, MD and Dorothy Abel, BSBME
How to Put Together an IDE Application
Adverse Event Reporting: Trials and Tribulations
Criteria for Approval Is an IND Required? Devices
Welcome New IRB Members!
Bozeman Health Clinical Research
Device Review Decision Tree Version Date: 4/28/15 This decision tree to be used for studies involving research on a device ( approved or unapproved)
IRB BASICS: Ethics and Human Subject Protections
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Streamlining IRB Procedures for Expanded Access
IRB Educational Session - IRB Regulations on Expedited Review
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Opening an IND: Investigator Perspective
Er. Ajai Basil Consultant, Healthcare Technologies (Medical devices)
Office of Research Integrity and Protections
Presentation transcript:

Medical Devices IRB Determination IRB Member Continuing Education

AAHRRP Element II.2. D. Element II.2.D. The IRB or Ethics Committee has and follows written policies and procedures to conduct reviews by the convened IRB or Ethics Committee. Element II.2.D. The IRB or Ethics Committee has and follows written policies and procedures to conduct reviews by the convened IRB or Ethics Committee. 1.Element II.2.D.1. – Initial review 1.Element II.2.D.1. – Initial review 2.Element II.2.D.2. – Continuing review 2.Element II.2.D.2. – Continuing review 3.Element II.2.D.3. – Review of proposed modifications to previously approved research 3.Element II.2.D.3. – Review of proposed modifications to previously approved research

HRPP 2.5 Convened Meetings of the IRB The rationale for significant risk/non-significant risk device determinations; or the device is exempt from the IDE regulations. The rationale for significant risk/non-significant risk device determinations; or the device is exempt from the IDE regulations.

Three Basic Things 1. Does the study involve a device? 2. Is the devise SR or NSR? 3. Does the study need and IDE?

Definition of Medical Device An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent…a component, part o, or accessory….intended for a diagnosis of disease or condition or cure, mitigation, treatment, or prevention of disease or affects the structure or function of the body…and does not achieve primary purpose through chemical action…or being metabolized. An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent…a component, part o, or accessory….intended for a diagnosis of disease or condition or cure, mitigation, treatment, or prevention of disease or affects the structure or function of the body…and does not achieve primary purpose through chemical action…or being metabolized.

Significant Risk Device Presents a potential for serious risk to the health, safety or welfare of a subject. SR devices my include implants, devices that support or sustain human life, and devices that are substantially important in diagnosing, curing, mitigating or treating disease or in preventing impairment to human health.

How to Obtain IDE for a Study Using a Significant Risk Device Sponsor submits IDE application to FDA Sponsor submits IDE application to FDA FDA approves or disapproves FDA approves or disapproves After FDA approval and IRB approval the study can begin After FDA approval and IRB approval the study can begin

Non-Significant Risk (NSR) Device A device that is no significant risk. A device that is no significant risk. Examples: externally worn monitors for insulin reactions, gastroenterology and urology endoscopes and/or accessories, etc.

IDE for a Study Using Non- Significant Risk Device Sponsor presents the IRB with protocol and a brief explanation why the device is not a significant risk device. And, any other information requested by the IRB. Sponsor presents the IRB with protocol and a brief explanation why the device is not a significant risk device. And, any other information requested by the IRB. If the IRB determines the device is NSR and approves the study – the study is considered to have and approved application for IDE If the IRB determines the device is NSR and approves the study – the study is considered to have and approved application for IDE No formal IDE submission to FDA No formal IDE submission to FDA

NSR Device Studies IRB Responsibilities Review definitions Review definitions Review Sponsor’s brief explanation of why the devices is NSR and not SR Review Sponsor’s brief explanation of why the devices is NSR and not SR Conduct literature search Conduct literature search Search Internet Search Internet Ask FDA for assistance Ask FDA for assistance

Making the Risk Determination What is the basis for the risk? What is the basis for the risk? Proposed use of device Proposed use of device What is the nature of harm that may result from the use of the device What is the nature of harm that may result from the use of the device Any additional procedures Any additional procedures Potential harm from procedures Potential harm from procedures Consider how the device is used in the study and not the device alone. Consider how the device is used in the study and not the device alone.

Exempt Studies (exempt from 21 CFR 812) No IDE Needed Description of exempt devices [(21 CFR 812.2(c)] Description of exempt devices [(21 CFR 812.2(c)] -approved devices used in accordance with labeling -most in vitro diagnostic devices (IVDs) -consumer preference testing -testing of minor modification -testing of a combination of approved devices FDA post approval studies FDA post approval studies

IRB Responsibilities IRB’s should make the SR or NSR determination at a convened meeting. IRB’s should make the SR or NSR determination at a convened meeting. IRB should document its SR/NSR determination in the IRB meeting minutes. IRB should document its SR/NSR determination in the IRB meeting minutes. Maintain all other documentation. Maintain all other documentation.